ELTP Opinions 08/17/2014 14:24:19 $ELTP
Wow that is a 65% drop
nice post!!! well thought out and very well said!!! I agree with we are all here to make money, who am I or anybody else here to judge how some do it.
good luck to you and all here that "get it."
I'm riding my free shares all the way till we reach the bank!!!!!!
Funny the PPS was .068 when he became the CEO, looks like the PPS moved up to me.
Until after the RS.
Funny while Nasrat was CEO the PPS was .97 and now it is 034; looks like the PPS has moved down to me.
Incorrect of course.
Quote:
we will get to $2.10
After the RS.
the move from .35 to .97 will be a small bump compared to the run after FDA approves ELI200
What price will Nasrat sell Elite for ???
Thanks King of The "DD",
IB_
Because the next run that will take us past .97 is coming very soon? Just a hunch.
Didn't Nasrat sign on with Elite for 3 years?
He just past his one year mark.
This means we will be bought out within 2 years.
Hang onto your shares folks.
That's why I said I'm never selling. I'm waiting for the buyout in order to guarantee the max PPS.
Nasrat owns way too many shares. The only way he can sell them is by us getting bought out.
If he sold even one share and shareholders noticed this in the form 4, all hell would break loose, and this thing would TANK and Nasrat wouldn't be able to sell the rest of his shares.
Also, the BARE MINIMUM buy out price will be $2.10. BARE MINIMUM. We have it in writing.
I agree but Nasrat will wait as long as it takes before taking a buyout offer if he feels it isn't the best he can get. There's no reason for him to take a deal that is below market value for our technology. Elite now has the space, money, patents, resources to do it all on our own so that is great bargaining power.
Unless they give us exactly what WE want, then no deal. Simple as that. Now I do believe Nasrat is looking for a major deal here. As tangerine pointed out, did he really come here to work for 10 years making pills or did he come here to get the ship rolling and get a deal done?
You can come to your own conclusion but I feel i have a fairly good idea of how this is most likely going to play out in the next 12 months as we see more and more trial results released and Elite files their first NDA this December.
I generally agree but Elite will posture and grow to keep all the leverage. They have the cash, the tech and with Epic the manufacturing space to do huge things. Epic was and may still be the largest contract drug maker for a single drug company. 100k sq feet of space there.
My opinion is they will get bought out sooner then later. Most everyone knows it. Nasrat didnt take this spot to work for the next 10 years manufacturing drugs.
LOL LOL Yep, another Elite outsmarts Pfizer. LOL LOL hysterically funny.
What Nasrat most likely remembers, and Pfizer certainly does, is that within one week of Lipitor's (which was the biggest drug in history)patent expiration, it's sales fell by 50% The First WEEK! Lol. So they are putting all this money into Embeda for what? A new ART generic comes out, sells for a lot cheaper, and cuts Embeda sales in half less than a year after it's out? After all the R&D. And because of Elite's technology, Embeda's patent won't protect Embeda, so it's a whole shltload of Pfizer money down the tube again, but without even realizing it's true potential gains they were counting on.
Maybe there is the possibility Pfizer has stopped/slowed R&D investment in it because of the looming ELTP generic (not to mention their 16 more ART's)?
And, Nasrat will not need "education" by Pfizer to assist in educating the public to generic ARTs. Now a days, consumers are very sensitive to cost and find this themselves. It won't take them long to find a much cheaper alternative to Embeda. Like Lipitor...give them a week. Think Pfizer hasn't figured that out yet? Pfizer has a whole lot of problems right now, and we're one of them...just lurking on the horizon. My question is are they going to just walk away from a multi-billion dollar market because of a looming generic that they can't control, or take action to see that does not happen?
As an aside, Bayer paid Barr labs and a few others $50 mil plus quarterly payments to keep generic Cipro off the market for several years, totaling several hundred million. When Pfizer's Lipitor went off patent, the average 3-month price dropped from about 400-500, to like 30. Patients know. Then there was the the whole AndroGel stink...Activis paid Solvay like $30 mil a year for limited rights to their patent. Familiar names...and Nasrat isn't going to be taking a paltry $30 mil a year to piggy-backers for it's ART technology. BMY, ACT, PFE...what a lie-up of familiar names, with PFE seemingly the one with the most to lose given Embeda (which has seemed to suddenly be "delayed."
Something, it seems to me has to give at some point soon. No way PFE is just going to walk from the ART market given it's size, and not a damn thing they can do about Elite because the patent is completely different, and knows they can fund it's development without them.
ELTP's market cap is at 185 mil and selling at .34/share? No, that's not going to last long. Nas needs to get the sp up as high as possible, soon, to get the best possible deal. I don't think any kind of "partnership" is what's going on right now, and I don't think ELTP will be the one to bring the ART generics to market...they will likely be long snapped up by then, IMO.
GLTA.
Maz
Nice post! Plenty of noise as you point out, keep your eyes on the prize! Elite is growing and preparing itself to enter a market worth billions. They have righted the ship from when you and I started investing in this company in 2011 and have put out quarter after quarter of big revenue gains. It's nice to know that on the operations side, the business is self sustaining. Get one ART to market and several others follow in rapid succession. ....and we'll be stinking rich!
$ELTP
Hmmm I never said anything about that
Yes I agree Nasrat is going to launch a whole line of ART products and not a damn thing anybody here is going to do about it. LMAO
Wow that is a 65% drop
nice post!!! well thought out and very well said!!! I agree with we are all here to make money, who am I or anybody else here to judge how some do it.
good luck to you and all here that "get it."
I'm riding my free shares all the way till we reach the bank!!!!!!
Funny the PPS was .068 when he became the CEO, looks like the PPS moved up to me.
Until after the RS.
Funny while Nasrat was CEO the PPS was .97 and now it is 034; looks like the PPS has moved down to me.
Incorrect of course.
Quote:
we will get to $2.10
After the RS.
the move from .35 to .97 will be a small bump compared to the run after FDA approves ELI200
What price will Nasrat sell Elite for ???
Thanks King of The "DD",
IB_
Because the next run that will take us past .97 is coming very soon? Just a hunch.
Didn't Nasrat sign on with Elite for 3 years?
He just past his one year mark.
This means we will be bought out within 2 years.
Hang onto your shares folks.
That's why I said I'm never selling. I'm waiting for the buyout in order to guarantee the max PPS.
Nasrat owns way too many shares. The only way he can sell them is by us getting bought out.
If he sold even one share and shareholders noticed this in the form 4, all hell would break loose, and this thing would TANK and Nasrat wouldn't be able to sell the rest of his shares.
Also, the BARE MINIMUM buy out price will be $2.10. BARE MINIMUM. We have it in writing.
I agree but Nasrat will wait as long as it takes before taking a buyout offer if he feels it isn't the best he can get. There's no reason for him to take a deal that is below market value for our technology. Elite now has the space, money, patents, resources to do it all on our own so that is great bargaining power.
Unless they give us exactly what WE want, then no deal. Simple as that. Now I do believe Nasrat is looking for a major deal here. As tangerine pointed out, did he really come here to work for 10 years making pills or did he come here to get the ship rolling and get a deal done?
You can come to your own conclusion but I feel i have a fairly good idea of how this is most likely going to play out in the next 12 months as we see more and more trial results released and Elite files their first NDA this December.
I generally agree but Elite will posture and grow to keep all the leverage. They have the cash, the tech and with Epic the manufacturing space to do huge things. Epic was and may still be the largest contract drug maker for a single drug company. 100k sq feet of space there.
My opinion is they will get bought out sooner then later. Most everyone knows it. Nasrat didnt take this spot to work for the next 10 years manufacturing drugs.
LOL LOL Yep, another Elite outsmarts Pfizer. LOL LOL hysterically funny.
What Nasrat most likely remembers, and Pfizer certainly does, is that within one week of Lipitor's (which was the biggest drug in history)patent expiration, it's sales fell by 50% The First WEEK! Lol. So they are putting all this money into Embeda for what? A new ART generic comes out, sells for a lot cheaper, and cuts Embeda sales in half less than a year after it's out? After all the R&D. And because of Elite's technology, Embeda's patent won't protect Embeda, so it's a whole shltload of Pfizer money down the tube again, but without even realizing it's true potential gains they were counting on.
Maybe there is the possibility Pfizer has stopped/slowed R&D investment in it because of the looming ELTP generic (not to mention their 16 more ART's)?
And, Nasrat will not need "education" by Pfizer to assist in educating the public to generic ARTs. Now a days, consumers are very sensitive to cost and find this themselves. It won't take them long to find a much cheaper alternative to Embeda. Like Lipitor...give them a week. Think Pfizer hasn't figured that out yet? Pfizer has a whole lot of problems right now, and we're one of them...just lurking on the horizon. My question is are they going to just walk away from a multi-billion dollar market because of a looming generic that they can't control, or take action to see that does not happen?
As an aside, Bayer paid Barr labs and a few others $50 mil plus quarterly payments to keep generic Cipro off the market for several years, totaling several hundred million. When Pfizer's Lipitor went off patent, the average 3-month price dropped from about 400-500, to like 30. Patients know. Then there was the the whole AndroGel stink...Activis paid Solvay like $30 mil a year for limited rights to their patent. Familiar names...and Nasrat isn't going to be taking a paltry $30 mil a year to piggy-backers for it's ART technology. BMY, ACT, PFE...what a lie-up of familiar names, with PFE seemingly the one with the most to lose given Embeda (which has seemed to suddenly be "delayed."
Something, it seems to me has to give at some point soon. No way PFE is just going to walk from the ART market given it's size, and not a damn thing they can do about Elite because the patent is completely different, and knows they can fund it's development without them.
ELTP's market cap is at 185 mil and selling at .34/share? No, that's not going to last long. Nas needs to get the sp up as high as possible, soon, to get the best possible deal. I don't think any kind of "partnership" is what's going on right now, and I don't think ELTP will be the one to bring the ART generics to market...they will likely be long snapped up by then, IMO.
GLTA.
Maz
Nice post! Plenty of noise as you point out, keep your eyes on the prize! Elite is growing and preparing itself to enter a market worth billions. They have righted the ship from when you and I started investing in this company in 2011 and have put out quarter after quarter of big revenue gains. It's nice to know that on the operations side, the business is self sustaining. Get one ART to market and several others follow in rapid succession. ....and we'll be stinking rich!
$ELTP
Hmmm I never said anything about that
Yes I agree Nasrat is going to launch a whole line of ART products and not a damn thing anybody here is going to do about it. LMAO
